Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells.
Benallegue N, Nicol B, Lasselin J, Bézie S, Flippe L, Regue H, Vimond N, Remy S, Garcia A, Le Frère F, Anegon I, Laplaud D, Guillonneau C. Benallegue N, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 20;9(6):e200016. doi: 10.1212/NXI.0000000000200016. Print 2022 Nov. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36266052 Free PMC article.
Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.
Crockett AM, Ryan SK, Vásquez AH, Canning C, Kanyuch N, Kebir H, Ceja G, Gesualdi J, Zackai E, McDonald-McGinn D, Viaene A, Kapoor R, Benallegue N, Gur R, Anderson SA, Alvarez JI. Crockett AM, et al. Among authors: benallegue n. Brain. 2021 Jun 22;144(5):1351-1360. doi: 10.1093/brain/awab055. Brain. 2021. PMID: 33876226 Free PMC article.
Neuroinflammation: Extinguishing a blaze of T cells.
Benallegue N, Kebir H, Alvarez JI. Benallegue N, et al. Immunol Rev. 2022 Oct;311(1):151-176. doi: 10.1111/imr.13122. Epub 2022 Jul 31. Immunol Rev. 2022. PMID: 35909230 Free PMC article. Review.
Immune status of the murine 22q11.2 deletion syndrome model.
Crockett AM, Kebir H, Benallegue N, Adelman P, Gur RE, Sullivan K, Anderson SA, Alvarez JI. Crockett AM, et al. Among authors: benallegue n. Eur J Immunol. 2023 Jan;53(1):e2249840. doi: 10.1002/eji.202249840. Epub 2022 Dec 5. Eur J Immunol. 2023. PMID: 36337041 Free article.
Care of pharmaco-resistant absence seizures in childhood.
Le Roux M, Benallegue N, Gueden S, Rupin-Mas M, Van Bogaert P. Le Roux M, et al. Among authors: benallegue n. Rev Neurol (Paris). 2024 Apr;180(4):251-255. doi: 10.1016/j.neurol.2024.01.002. Epub 2024 Feb 21. Rev Neurol (Paris). 2024. PMID: 38388226 Free article. Review.
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
Benallegue N, Rollot F, Wiertlewski S, Casey R, Debouverie M, Kerbrat A, De Seze J, Ciron J, Ruet A, Labauge P, Maillart E, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Stankoff B, Clavelou P, Heinzlef O, Pelletier J, Thouvenot E, Al Khedr A, Bourre B, Casez O, Cabre P, Wahab A, Magy L, Vukusic S, Laplaud DA; OFSEP (Observatoire Français de la Sclérose en Plaques) Investigators. Benallegue N, et al. JAMA Neurol. 2024 Mar 1;81(3):273-282. doi: 10.1001/jamaneurol.2023.5566. JAMA Neurol. 2024. PMID: 38345791 Free PMC article.
11 results